Health

WATCH: Fauci says U.S. to spend $3.2 billion on antiviral pills for COVID-19

WASHINGTON (AP) — The United States is devoting $3.2 billion to advance development of antiviral pills for COVID-19 and other dangerous viruses that could turn into pandemics.

Watch the briefing in the video player above.

Dr. Anthony Fauci, the nation’s top infectious disease expert, announced the investment during a White House briefing as part of a new “antiviral program for pandemics” to develop drugs to address symptoms caused by potentially dangerous viruses like the coronavirus.

The pills for COVID-19, which would be used to minimize symptoms after infection, are in development and could begin arriving by year’s end, pending the completion of clinical trials. The funding will speed those clinical trials and provide additional support private sector research, development and manufacturing.

Fauci said the new program would invest in “accelerating things that are already in progress” for COVID-19, but also work to innovate new therapies for other viruses.

“There are few treatments that exist for many of the viruses that have pandemic potential,” said Fauci.

But he added, “vaccines clearly remain the centerpiece of our arsenal.”

News of the administration’s plans for the pill was first reported Thursday by The New York Times.

You May Also Like

World

France, which has opened its borders to Canadian tourists, is eager to see Canada reopen to the French. The Canadian border remains closed...

Health

Kashechewan First Nation in northern Ontario is experiencing a “deepening state of emergency” as a result of surging COVID-19 cases in the community...

World

The virus that causes COVID-19 could have started spreading in China as early as October 2019, two months before the first case was identified in the central city of Wuhan, a new study...

World

April Ross and Alix Klineman won the first Olympic gold medal for the United States in women’s beach volleyball since 2012 on Friday,...

© 2021 Newslebrity.com - All Rights Reserved.